1. Home
  2. CHOW vs SNTI Comparison

CHOW vs SNTI Comparison

Compare CHOW & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ChowChow Cloud International Holdings Limited Ordinary Shares

CHOW

ChowChow Cloud International Holdings Limited Ordinary Shares

N/A

Current Price

$3.49

Market Cap

12.7M

Sector

Technology

ML Signal

N/A

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

N/A

Current Price

$0.15

Market Cap

10.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CHOW
SNTI
Founded
2014
2016
Country
Hong Kong
United States
Employees
17
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.7M
10.4M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
CHOW
SNTI
Price
$3.49
$0.15
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $13.50
AVG Volume (30 Days)
★ 11.2M
1.2M
Earning Date
01-01-2027
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 77.31
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$127.27
Revenue Next Year
N/A
N/A
P/E Ratio
$10.80
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.20
$0.14
52 Week High
$12.05
$57.60

Technical Indicators

Market Signals
Indicator
CHOW
SNTI
Relative Strength Index (RSI) 65.64 14.74
Support Level $0.35 $0.15
Resistance Level $7.38 $0.24
Average True Range (ATR) 0.92 0.03
MACD 0.05 0.23
Stochastic Oscillator 31.49 14.86

Price Performance

Historical Comparison
CHOW
SNTI

About CHOW ChowChow Cloud International Holdings Limited Ordinary Shares

ChowChow Cloud International Holdings Ltd provides one-stop cloud solutions that support companies across the IT industry value chain throughout their entire cloud transformation journey, from consulting, deployment, and migration to cloud environment building and management. Its business comprises (i) digital transformation consulting services consisting of cloud suitability assessment, (ii) professional IT services comprising capabilities designed to facilitate seamless cloud integration and digital transformation, (iii) AI-powered proactive cloud managed services covering all aspects of day-to-day cloud maintenance and support, and (iv) IT infrastructure solutions covering on-premise private cloud setups and public cloud integrations, including infrastructure applications.

About SNTI Senti Biosciences Inc.

Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).

Share on Social Networks: